FIT1 Activators
FIT1 Activators are a set of chemical compounds that directly or indirectly enhance the functional activity of FIT1, a protein involved in specific cellular signaling pathways. Epinephrine binds to adrenergic receptors and triggers a signaling cascade that increases intracellular cAMP levels, activating PKA, which in turn can phosphorylate FIT1 or its regulatory proteins, thereby enhancing its activity. Caffeine, a known phosphodiesterase inhibitor, prevents the breakdown of cAMP, effectively increasing PKA activity, which is a mechanism that can lead to the activation of FIT1. Similarly, Forskolin stimulates adenylate cyclase, raising cAMP levels and activating PKA, which may lead to the phosphorylation and activation of FIT1 or its associated proteins.
Moreover, IBMX, by inhibiting phosphodiesterases, increases cAMP and cGMP levels, resulting in the activation of PKA or PKG, which may phosphorylate FIT1 or proteins in its regulatory pathway, enhancing FIT1 activity. U0126 acts as a MEK inhibitor, modulating the MAPK/ERK pathway and reducing the activity of proteins that negatively regulate FIT1, thereby enhancing FIT1 activity. Phosphatidic Acid acts as a second messenger in signaling and can activate mTOR, which in turn may promote the phosphorylation of proteins that interact with FIT1, leading to its enhanced activity. Resveratrol, through the activation of SIRT1, can induce the deacetylation of regulatory proteins of FIT1, which in turn enhances FIT1 activity. Sphingosine-1-phosphate and lysophosphatidic acid both function through receptor-mediated mechanisms to activate downstream kinases like PI3K/Akt and Rho/Rac, respectively, which can lead to changes that enhance the activity of FIT1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which leads to the activation of adenylate cyclase and an increase in cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and enhance the activity of FIT1 by phosphorylating it directly or its regulatory proteins. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits phosphodiesterases, leading to increased cAMP levels due to reduced cAMP breakdown. This elevation in cAMP can enhance PKA activity, which may lead to the activation of FIT1 through phosphorylation processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, which increases intracellular cAMP levels, leading to the activation of PKA. PKA can then phosphorylate FIT1 or proteins in its activation pathway, enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which leads to increased cAMP and cGMP levels. This can result in the activation of PKA or PKG, which may phosphorylate FIT1 or associated regulatory proteins, leading to its enhanced activity. | ||||||
Phosphatidic Acid, Dioleoyl | 108392-02-5 | sc-201059 | 10 mg | $255.00 | 1 | |
Phosphatidic Acid can act as a second messenger in signal transduction and may activate mTOR. mTOR activation can enhance FIT1 activity by promoting phosphorylation of proteins that interact with or regulate FIT1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate binds to its receptors, leading to activation of PI3K/Akt pathway. Akt can phosphorylate substrates that may regulate FIT1 activity, leading to its enhancement. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid interacts with its G protein-coupled receptors, stimulating the Rho/Rac pathway which can modulate actin cytoskeleton dynamics. This modulation can enhance FIT1 activity by altering the cellular microenvironment. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which can lead to reduced activity of the MAPK/ERK pathway. By inhibiting negative regulators within this pathway, there can be an indirect enhancement of FIT1 activity. | ||||||